Vertex Pharmaceuticals Inc / Ma

D. E. Shaw & Co., Inc. VRTX

Report date

9/30/2025

Quarter

2025 Q3

Filed

11/14/2025

Shares

3,343

Value ($000)

1,309

Weight

0.0%

2013 Q4 - 2025 Q3 (25 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q3	11/14/2025	1,309	0.0%	3,343	9/30/2025
2025 Q2	8/14/2025	8,940	0.0%	20,081	6/30/2025
2025 Q1	5/15/2025	34,875	0.0%	71,933	3/31/2025
2024 Q4	2/14/2025	106,991	0.1%	265,684	12/31/2024
2024 Q3	11/14/2024	64,371	0.1%	138,408	9/30/2024
2024 Q2	8/14/2024	79,712	0.1%	170,063	6/30/2024
2023 Q4	2/14/2024	86,660	0.1%	212,981	12/31/2023
2023 Q3	11/14/2023	89,367	0.1%	256,993	9/30/2023
2023 Q2	8/14/2023	88,596	0.1%	251,758	6/30/2023
2023 Q1	5/15/2023	64,568	0.1%	204,932	3/31/2023
2022 Q4	2/14/2023	31,920	0.1%	110,533	12/31/2022
2022 Q3	11/14/2022	34,239	0.1%	118,253	9/30/2022
2022 Q2	8/15/2022	78,547	0.1%	278,744	6/30/2022
2022 Q1	5/16/2022	194,226	0.3%	744,248	3/31/2022
2021 Q4	2/14/2022	224,283	0.3%	1,021,323	12/31/2021
2021 Q3	11/15/2021	311,017	0.4%	1,714,634	9/30/2021
2021 Q2	8/16/2021	156,669	0.2%	777,015	6/30/2021
2021 Q1	5/17/2021	117,464	0.1%	546,624	3/31/2021
2020 Q4	2/16/2021	206,644	0.2%	874,348	12/31/2020
2020 Q3	11/16/2020	95,552	0.1%	351,138	9/30/2020
2020 Q2	8/14/2020	42,916	0.1%	147,830	6/30/2020
2020 Q1	5/15/2020	70,716	0.1%	297,187	3/31/2020
2019 Q4	2/14/2020	81,881	0.1%	373,973	12/31/2019
2014 Q1	5/15/2014	134,212	0.3%	1,897,799	3/31/2014
2013 Q4	2/14/2014	53,670	0.1%	722,340	12/31/2013